医学
置信区间
轮廓
骶骨
放射肿瘤学家
放射治疗
放射科
核医学
外科
内科学
工程类
工程制图
作者
Emma Dunne,Arjun Sahgal,Simon S. Lo,Alanah Bergman,Robert Kosztyla,Nicolas Dea,Eric L. Chang,Ung‐Kyu Chang,Samuel T. Chao,Salman Faruqi,Amol J. Ghia,Kristin J. Redmond,Scott G. Soltys,Mitchell C. Liu
标识
DOI:10.1016/j.radonc.2019.11.026
摘要
Abstract Background and purpose To interrogate inter-observer variability in gross tumour volume (GTV) and clinical target volume (CTV) delineation specific to the treatment of sacral metastases with spinal stereotactic body radiation therapy (SBRT) and develop CTV consensus contouring recommendations. Materials and methods Nine specialists with spinal SBRT expertise representing 9 international centres independently contoured the GTV and CTV for 10 clinical cases of metastatic disease within the sacrum. Agreement between physicians was calculated with an expectation minimisation algorithm using simultaneous truth and performance level estimation (STAPLE) and with kappa statistics. Optimised confidence level consensus contours were obtained using a voxel-wise maximum likelihood approach and the STAPLE contours for GTV and CTV were based on an 80% confidence level. Results Mean GTV STAPLE agreement sensitivity and specificity was 0.70 (range, 0.54–0.87) and 1.00, respectively, and 0.55 (range, 0.44–0.64) and 1.00 for the CTV, respectively. Mean GTV and CTV kappa agreement was 0.73 (range, 0.59–0.83) and 0.59 (range, 0.41–0.70), respectively. Optimised confidence level consensus contours were identified by STAPLE analysis. Consensus recommendations for the CTV include treating the entire segment containing the disease in addition to the immediate adjacent bony anatomic segment at risk of microscopic extension. Conclusion Consensus recommendations for CTV target delineation specific to sacral metastases treated with SBRT were established using expert contours. This is a critical first step to achieving standardisation of target delineation practice in the sacrum and will serve as a baseline for meaningful pattern of failure analyses going forward.
科研通智能强力驱动
Strongly Powered by AbleSci AI